Dogwood IMC-2 Eases Long-COVID Symptoms, Daytime Sleepiness Triples Dementia Risk, NSAIDs Double Bleeding Risk, Migratory Birds Spread Ticks, and more...

(0:10): Dogwood's IMC-2 Shows Promise in Reducing Long-COVID Fatigue and Sleep Issues(2:03): Study Links Daytime Sleepiness to Tripled Dementia Risk, Emphasizes Sleep's Role in Cognitive Health(4:23): Study Warns NSAIDs Double Bleeding Risk for Anticoagulant Patients: Ibuprofen, Diclofenac, Naproxen Highlighted(6:47): Study Reveals Migratory Birds Aid Rapid Spread of Ticks Across U.S., Climate Change Worsens Threat(8:52): New Oral Tablet Infigratinib Boosts Growth in Children with Achondroplasia, Study FindsTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: Le Monde